Shah Parag Suresh 4
4 · Bellerophon Therapeutics, Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
- Award
Stock Options (Right to Buy)
2023-06-07−50,000→ 50,000 totalExercise: $0.83Exp: 2033-06-07→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023.
- [F2]This option vests in 16 quarterly installments commencing on the date hereof.